Fengyong Liu
Papers
4
Total Citations
181
H-Index
4
About
Dr. Fengyong Liu is a pioneering urologic surgeon whose research focuses on the surgical management of renal cell carcinoma (RCC) complicated by inferior vena cava (IVC) tumor thrombus. His major contributions center on advancing minimally invasive, robot-assisted techniques for these complex, high-risk procedures. Dr. Liu’s landmark 2019 study, cited 99 times, provided the first detailed, step-by-step protocol for robot-assisted Level III-IV IVC thrombectomy, demonstrating its feasibility and reporting one-year outcomes. He further refined surgical decision-making with a 2020 multi-institutional analysis (54 citations) that established a scheme for choosing between robot-assisted cavectomy and thrombectomy for Level II thrombi. Notably, his work includes the initial series describing robotic segmental IVC resection for left-sided RCC with caval thrombus, and he has innovated in nephron-sparing surgery by applying hypothermic perfusion via a renal artery balloon catheter during robot-assisted partial nephrectomy to preserve renal function. Through these high-impact studies, Dr. Liu has been instrumental in expanding the boundaries of robotic surgery, offering patients with advanced RCC safer, less invasive alternatives to traditional open surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4